A lipid droplet-specific fluorescence probe for atherosclerotic plaque imaging

Analyst. 2022 Jun 27;147(13):3081-3086. doi: 10.1039/d1an01937f.

Abstract

The dysregulation of lipid droplets (LDs) is closely related to certain metabolic diseases, while the role of LDs during pathological processes remains mysterious. It would be of great value to monitor the dynamic changes of LDs in a visible way so as to study their biological functions. In this study, we report a LD-specific fluorescence probe TBI for precise LD-targeting imaging in cells and atherosclerotic tissues. TBI exhibited great biocompatibility, remarkable oil-enhanced fluorescence emission, good photostability and impressive intracellular and tissular LD-specific imaging performance. Importantly, TBI could efficiently stain the LDs at a low concentration of 50 nM, and the motion tracking of LDs could be observed via fluorescence imaging. Moreover, TBI could efficiently light up the LD distribution in mouse atherosclerotic plaques with high resolution, which revealed the ultra-structure of atherosclerotic plaques. In conclusion, these results imply that TBI could be a potential tool for investigating the physiological and pathological role of LDs.

MeSH terms

  • Animals
  • Fluorescent Dyes / chemistry
  • Lipid Droplets* / metabolism
  • Mice
  • Optical Imaging
  • Plaque, Atherosclerotic* / diagnostic imaging

Substances

  • Fluorescent Dyes